Sidharth Harindranath MD DM
@hsid_h
Followers
287
Following
1K
Media
15
Statuses
134
Assistant Professor, Department of gastroenterology, KEM hospital Special interest in Pancreatology, IBD and therapeutic endoscopy
Mumbai, India
Joined December 2014
Privileged to have contributed to this collaborative effort. Thank you @ibdseb @drvishal82 @giri_gutnliver @DrAnuraagJ for the opportunity and guidance! #IBD
Stigma in #IBD is still prevalent and needs to be identified & addressed This SR from the team led by @giri_gutnliver gives some important pointers ⏺️Need standardised terminology and assessment ⏺️Awareness , support , advocacy and psychological interventions
0
0
5
Stigma & fatigue remain less commonly addressed issues in managing patients with IBD...Check out articles addressing the same with @DrAnuraagJ @drpreetamnath @drvishal82 @AKSHAYK49225783 @hsid_h Stigma in IBD: https://t.co/eFCoxo0Kl4 Fatigue in IBD: https://t.co/sKepIdutRR
2
20
46
It was a pleasure presenting with you! Thank you for the @ECCO style slide decks!
🎯 Great day at the @HospitalHinduja IBD Meet 2025! Had the pleasure of discussing CD guidelines (@ECCO-style!) with @hsid_h — Innovative💡 by Dr Devendra Desai 👏 Moderated insightful @BowelUltrasound panel with @Kayalvn Kudos to @DhoblePavan for excellent quiz & hospitality!🤝
1
0
12
🚀 Excited to introduce the ChatIBD Beta: an AI platform to support IBD clinicians in accessing IBD guidelines • Global access/multi-lingual • Guideline-grounded answers • Curated dosing database Link and technical deep dive below 👇
4
31
121
💡Are you interested in how to position and use p19 in clinical practice? @YOGI_IBD presents this fantastic overview where global young IBD leaders take the stage💃🏻 Join us tomorrow!!! 👇🏻👇🏻👇🏻 4 pm Central Europe Time ⏰ @JosephHabibi_MD 🥇
4
15
33
Check out our recently published review on BCS and pregnancy in the @JCEH_Hepatology journal, co-authored with @sayan006GI , @taraprasad . #livertwitter Check out the full manuscript: https://t.co/MGqLXaFB6P
0
16
45
Our upcoming global education webinar is here, w/ a 🤩team of YOGIs and experts ⭐️Discuss p19s and p40 biosimilars ⭐️Share global insight on use (& challenges) in practice ⏲️Sep, 26, 10 AM EST Sign up: https://t.co/7hvETqWPvU For YOGI newsletter: https://t.co/N1CLHdfblB
1
13
30
🇮🇳 Data reaffirming the association of HLA haplotype in azathioprine induced pancreatitis in IBD #GITwitter @IJG_Journal @ibdseb @IBDimmunology @Bealoquebea @drvishal82 @doctorboletoh @KailashKolhe @DrAnuraagJ @sanjy_med @dr_singh_gastro @drbiswaPATRA
https://t.co/bHarpYSPAw
1
8
27
Role of prehabilitative gastrostomy tube feeding to bridge severely malnourished surgically unfit achalasia patients to per-oral endoscopic myotomy @drbiswaPATRA #DrAkashShukla
https://t.co/GfbocElenB
0
5
6
Thanks team #KPLD2025 for a unique theme, thought provoking case discussions, insightful lectures, and amazing hospitality! Special thanks to @giri_gutnliver @DrAnuraagJ Masterful talks by @drvishal82 @drsridhars #GITwitter
0
0
6
This was special! First ECCO congress. Amazing talks! Thrilled to have presented my work! 🇮🇳 Great time with friends, colleagues and world experts! #ECCO2025 #IBD @Y_ECCO_IBD
2
0
19
@gilkaplan #ECCO2025 Brilliant and clear lecturer IBD epidemiology modelling to highlight WHAT is coming our way and WHEN in global #IBD 🤔potential avenues to meet global 🌎#IBD challenges
1
11
26
1
5
32
⏺️#IBD is global 🌎 disease➡️needs global 🌎 solutions. ⏺️Transcontinental &transethnic comparisons & collaborations are 🔑 ⏺️👇scoping review lays the ground work to address the challenges &grasp the opportunities 🙏🏼 @DrAnuraagJ @ShenoyShabari #Manasi for driving this
3
19
43
Thiopurines remain an important therapy for #IBD in the LMIC regions. Can they still be used in those with NUDT15 polymorphisms? Our real world data in regarding thiopurine use in those with NUDT15 heterozygous status is now published https://t.co/rNNgbLe8b4
2
23
60
The incidence and prevalence of IBD 🚻 in India 🇮🇳 lower compared to the global population 🌏 but are increasing 📈 at a faster rate than the global population. Check out the recent GBD data with @DrAnuraagJ @drvishal82 @drpreetamnath
https://t.co/zD3TmfEuVy
irjournal.org
Burden of inflammatory bowel disease in India: analysis of the Global Burden of Disease study from 1990 to 2019
5
12
51
A comprehensive review on managing latent TB before advanced therapies in autoimmune, dermatological diseases and IBD. Also, we focus on approach in TB endemic regions Do read this brilliant and massive effort led by @JhaDayakrishna and @RinkalKakadiya
https://t.co/traWqvOnaL
Our latest review on Latent TB in advanced therapy among IMIDs and IBD patients. Assessment and management for latent tuberculosis before advanced ther... https://t.co/gyTt1YqJNP
@drvishal82 @RinkalKakadiya @DrAnuraagJ @DrAnuragSachan @ibd_pal
4
33
86
Happy to write this review with #DrDDesai on the exciting potential of wearable devices in the management of IBD #GITwitter #IBD
@DrAnuraagJ @ibd_pal @ibdseb @charlie_lees @IBDimmunology @Bealoquebea @stevenbollipo @P_DeepakIBDMD @drvishal82 @gut_rp
9
4
43